1887

Abstract

The immunogenicity and antigenicity of an enzymatically functional (ATPase/helicase) recombinant protein encompassing residues 1207–1612 of the hepatitis C virus (HCV) non-structural 3 (NS3) protein was characterized using B10 congenic mice. Previous studies have indicated a high frequency of NS3-specific antibodies in HCV-infected humans. Similarly, all six immunized murine haplotypes were antibody responders to the NS3 ATPase/helicase domain, with the H-2 and H-2 haplotypes as high responders. As also observed in HCV-infected humans, the murine NS3 antibodies were predominantly directed to conformational determinants. Irrespective of the murine haplotype, IgG1 predominated in the primary anti-NS3 response, whereas IgG1 and IgG2b predominated in the secondary response. The antibody responder hierarchy was reiterated at the T cell level, with the H-2 and the H-2 haplotypes as the best responders. In both the H-2 and H-2 haplotypes ATPase/helicase-primed T cells secreted interleukin 2 and interferon γ, corroborating observations from HCV-infected humans. In the H-2, H-2 and H-2 haplotypes the fine specificity of the T cell recognition of the ATPase/helicase domain was further characterized. Multiple, although generally weak, T cell recognition sites were found for all three haplotypes. The large size of the NS3 protein together with the presence of multiple class II binding motifs explain the high prevalence of NS3 antibodies in immunized mice and predict a similar explanation for the observed high frequency of NS3-specific antibodies in HCV-infected humans.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-11-2721
1996-11-01
2022-01-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/11/JV0770112721.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-11-2721&mimeType=html&fmt=ahah

References

  1. Bartenschlager R., Ahlborn L. L., Mous J., Jacobsen H. 1993; Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. Journal of Virology 67:3835–3844
    [Google Scholar]
  2. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J., Weiner A. J., Bradley D. W., Kuo G., Houghton M. 1991; Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences, USA 88:2451–2455
    [Google Scholar]
  3. Diepolder H. M., Zachoval R., Hoffman R. M., Wierenga E. A., Sanantonio T., Jung M.-C., Eichenlaub D., Pape G. R. 1995; Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007
    [Google Scholar]
  4. Erickson A. L., Houghton M., Choo Q. L., Weiner A. J., Ralston R., Muchmore E., Walker C. M. 1993; Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. Journal of Immunology 151:4189–4199
    [Google Scholar]
  5. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., Schianchi C., Missale G., Marin M. G., Fiaccadori F. 1994; T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286–295
    [Google Scholar]
  6. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993a; Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. Journal of Virology 67:2832–2843
    [Google Scholar]
  7. Grakoui A., Wychowski C., Lin C., Feinstone S., Rice C. M. 1993b; Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67:1385–1395
    [Google Scholar]
  8. Hoffmann R. M., Diepolder H. M., Zachoval R., Zwiebel F.-M., Jung M.-C., Schloz S., Nitschko H., Riethmuller G., Pape G. R. 1995; Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21:632–638
    [Google Scholar]
  9. Inchauspe G., Zebedee S., Lee D.-H., Sugitani M., Nasoff M., Prince A. M. 1991; Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proceedings of the National Academy of Sciences, USA 88:10292–10296
    [Google Scholar]
  10. Iwata K., Wakita T., Okumura A., Yoshioka K., Takayanagi M., Wands J., Kakumu S. 1995; Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 22:1057–1064
    [Google Scholar]
  11. Jin L., Peterson D. L. 1995; Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Archives of Biochemistry and Biophysics 323:47–53
    [Google Scholar]
  12. Kakimi K., Kuribayashi K., Iwashiro M., Masuda T., Sakai M., Ling W., Kubo Y., Kobayashi H., Higo K., Seki M., Honda Y., Yamada E., Matsuura Y., Miyamura T., Okuma M., Ishimoto A. 1995; Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice. Journal of General Virology 76:1205–1214
    [Google Scholar]
  13. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. 1990; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences, USA 87:9524–9528
    [Google Scholar]
  14. Khudyakov Y. E., Khudyakova N. S., Jue D. L., Lambert S. B., Fang S., Fields H. A. 1995; Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology 206:666–672
    [Google Scholar]
  15. Lok A. S., Chien D., Choo Q.-L., Chan T. M., Chiu E. K., Cheng T. K., Houghton M., Kuo G. 1993; Antibody response to core, envelope, and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18:497–502
    [Google Scholar]
  16. Milich D. R., McLachlan A., Thornton G. B., Hughes J. L. 1987; Immune response to hepatitis B virus core antigen HBcAg: localization of T cell recognition sites within HBcAg/HBeAg. Journal of Immunology 139:1223–1231
    [Google Scholar]
  17. Milich D. R., Peterson D. L., Schodel F., Jones J. E., Hughes J. L. 1995; Preferential recognition of hepatitis B nucleocapsid antigens by Th1 and Th2 cells is epitope and major histocompatibility complex dependent. Journal of Virology 69:2776–2785
    [Google Scholar]
  18. Okamoto H., Kurai K., Okada S. I., Yamamoto K., Lizuka H., Tanaka T., Fukuda S., Tsuda F., Mishiro S. 1992; Full-length sequence of a hepatitis-C virus genome having poor homology to reported isolates -comparative study of four distinct genotypes. Virology 188:331–341
    [Google Scholar]
  19. Simmonds P., Rose K. A., Graham S., Chan S. W., McOmish F., Dow B. C., Follett E. A., Yap P. L., Marsden H. 1993; Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. Journal of Clinical Microbiology 31:1493–1503
    [Google Scholar]
  20. Sällberg M., Rude N. U., Magnius L. O., Norrby E., Wahren B. 1991; Rapid ′tea-bag′ peptide synthesis using 9-fluorenylmethoxy-carbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunology Letters 30:59–68
    [Google Scholar]
  21. Sällberg M., Ruden U., Wahren B., Magnius L. O. 1992; Immunodominant regions within the hepatitis-C virus core and putative matrix proteins. Journal of Clinical Microbiology 30:1989–1994
    [Google Scholar]
  22. Sällberg M., Rudé N. U., Wahren B., Magnius L. O. 1993; Antigenic regions within the hepatitis C virus envelope 1 and nonstructural proteins: identification of an IgG3 restricted recognition site within the envelope 1 protein. Clinical and Experimental Immunology 91:489–494
    [Google Scholar]
  23. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. 1991; Structure and organization of the hepatitis C virus genome isolated from human carriers. Journal of Virology 65:1105–1113
    [Google Scholar]
  24. Weiner A. J., Erickson A. L., Kansopon J., Crawford K., Muchmore E., Hughes A. L., Houghton M., Walker C. M. 1995; Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape mutant. Proceedings of the National Academy of Sciences, USA 92:2755–2759
    [Google Scholar]
  25. Zhang Z. X., Sönnerborg A., Sallberg M. 1994; A cell-binding Arg-Gly-Asp sequence is present in close proximity to the major linear antigenic region of HCV. Biochemical and Biophysical Research Communications 202:1352–1356
    [Google Scholar]
  26. Zhang Z. X., Chen M., Weiland O., Sönnerborg A., Sällberg M. 1995; Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site directed serology of the HCV structural proteins. Journal of Infectious Diseases 171:1356–1359
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-11-2721
Loading
/content/journal/jgv/10.1099/0022-1317-77-11-2721
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error